Gracell Biotechnologies

Gracell Biotechnologies

Gracell Biotechnologies

Gracell Biotechnologies is a developer of cancer immune therapy designed to treat cancer.
Founded
2017
Raised
$100M
Follow us
Latest funding
$100,000,000
Venture capital (Series C) - 2020
Wellington Management Temasek Holdings OrbiMed +4
Team Size
1–10
Employees
Location
Headquarters
Pulse 2.0

Gracell Biotechnologies (GRCL) Stock Price: Why It Increased Over 15% Today

Pulse 2.0

Gracell Biotechnologies (GRCL) Stock Price: Why It Increased Over 14% Today

Pulse 2.0

Gracell Biotechnologies (GRCL) Stock: Why The Price Surged Today

Pulse 2.0

Gracell Biotechnologies (GRCL) Stock: Why The Price Jumped Up Today

Pulse 2.0

Gracell Biotechnologies (GRCL) Stock: Why The Price Surged Today

$100,000,000 Venture capital (Series C)
ChinaMoneyNetwork , DealStreetAsia

CAR-T Biotech Firm Gracell Completes $100 Million Round – China Money Network